ANNX - Annexon, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.05 0.03 (0.98%)	---	0.0 (0.0%)	0.04 (1.32%)	0.0 (0.0%)	0.04 (1.33%)	0.03 (0.98%)	0.03 (0.98%)

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.34
Diluted EPS:: -0.34
Basic P/E:: -9.0588
Diluted P/E:: -9.0588
RSI(14) 1m:: 100.0
VWAP:: 3.08
RVol:: 0.7766

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.04 +0.04 (+1.17%)	Oct 15 15:26
1m	Price increase 1m	3.17 +0.04 (+1.37%)	Oct 15 09:55
60m	Price increase 60m	3.17 +0.17 (+5.6%)	Oct 15 09:55
1m	Price increase 1m	3.12 +0.06 (+1.91%)	Oct 15 09:45